Literature DB >> 17147698

Increased cerebral activity in Parkinson's disease patients carrying the DRD2 TaqIA A1 allele during a demanding motor task: a compensatory mechanism?

D Bartrés-Faz1, M J Martí, C Junqué, C Solé-Padullés, M Ezquerra, L B C Bralten, C Gaig, J Campdelacreu, J M Mercader, E Tolosa.   

Abstract

Previous studies suggest that neuroimaging techniques are useful for detecting the effects of functional genetic polymorphisms on brain function in healthy subjects or in patients presenting with psychiatric or neurodegenerative conditions. Former evidence showed that individuals carrying risk alleles displayed broader patterns of brain activity during behavioural and cognitive tasks, despite being clinically comparable to non-carriers. This suggests the presence of compensatory brain mechanisms. In the present study, we investigated this effect in Parkinson's disease (PD) patients carrying the DRD2 TaqIA A1 allelic variant. This variant may confer an increased risk of developing the disease and/or influence the clinical presentation. During a complex sequential motor task, we evidenced by functional magnetic resonance imaging that A1 allele carriers activated a larger network of bilateral cerebral areas than non-carriers, including cerebellar and premotor regions. Both groups had similar clinical and demographic measures. In addition, their motor performance during the functional magnetic resonance experiment was comparable. Therefore, our conclusions, pending replication in a larger sample, seem to reflect the recruitment of compensatory cerebral resources during motor processing in PD patients carrying the A1 allele.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17147698     DOI: 10.1111/j.1601-183X.2006.00290.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  3 in total

1.  The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment.

Authors:  Yan Ting Liu; Fang Liu; Lei Cao; Li Xue; Wei Ting Gu; Yong Zhi Zheng; Hao Tang; Yu Wang; Hong Yao; Yong Zhang; Wan Qun Xie; Bo Han Ren; Zhuo Hui Xiao; Ying Jie Nie; Ronggui Hu; Zhe Bao Wu
Journal:  Acta Neuropathol       Date:  2020-06-22       Impact factor: 17.088

2.  Association between the DRD2 TaqIA gene polymorphism and Parkinson disease risk: an updated meta-analysis.

Authors:  Ming Yu; Feiran Huang; Wei Wang; Chen Zhao
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

3.  DRD2 Taq1A Polymorphism-Related Brain Volume Changes in Parkinson's Disease: Voxel-Based Morphometry.

Authors:  Kenji Ohira; Hajime Yokota; Shigeki Hirano; Motoi Nishimura; Hiroki Mukai; Takuro Horikoshi; Setsu Sawai; Yoshitaka Yamanaka; Tatsuya Yamamoto; Shingo Kakeda; Satoshi Kuwabara; Tomoaki Tanaka; Takashi Uno
Journal:  Parkinsons Dis       Date:  2022-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.